Sigma-2 receptor ligand anchored telmisartan loaded nanostructured lipid particles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in prostate cancer cells

References

• Jain S, Saxena S, Kumar A. Epidemiology of prostate cancer in India. Meta Gene 2014;2:596–605.
   PubMedGoogle Scholar
• Brawley OW. Trends in prostate cancer in the United States. J Natl Cancer Inst Monogr 2012;45:152–6.
   Google Scholar
• D'Souza ND, Murthy NS, Aras RY. Projection of cancer incident cases for India-till 2026. Asian Pac J Cancer Prev 2013;14:4379–86.
   PubMedGoogle Scholar
• Leonard GG. Addressing the needs of the high-risk prostate cancer patient. Rev Urol 2005;7:S18–28.
   Google Scholar
• Takahashi S, Uemura H, Seeni A, et al. Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer. Prostate 2012;72:1559–72.
   PubMed Web of Science ®Google Scholar
• Semenas J, Allegrucci C, Boorjian SA, et al. Overcoming drug resistance and treating advanced prostate cancer. Curr Drug Targets 2012;13:1308–23.
   PubMed Web of Science ®Google Scholar
• Ishiguro H, Ishiguro Y, Kubota Y, et al. Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action. Prostate 2007;67:924–32.
   PubMed Web of Science ®Google Scholar
• Funao K, Matsuyama M, Kawahito Y, et al. Telmisartan as a peroxisome proliferator-activated receptor-γ ligand is a new target in the treatment of human renal cell carcinoma. Mol Med Rep 2009;2:193–8.
   PubMed Web of Science ®Google Scholar
• Funao K, Matsuyama M, Kawahito Y, et al. Telmisartan is a potent target for prevention and treatment in human prostate cancer. Oncol Rep 2008;20:295–300.
   PubMed Web of Science ®Google Scholar
• Kaur M, Bhatia RK, Pissurlenkar RRS, et al. Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells. Carbohydr Polym 2014;101:614–22.
   PubMed Web of Science ®Google Scholar
• Marasini N, Tran TH, Poudel BK, et al. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. Int J Pharm 2013;441:424–32.
   PubMed Web of Science ®Google Scholar
• Wienen W, Entzeroth M, Meel JCA, et al. A review on telmisartan: a novel, long-acting angiotensin II-receptor antagonist. Cardiovas Drug Rev 2000;18:127–54.
   Google Scholar
• Stangier J, Schmid J, Turck D, et al. Absorption, metabolism, and excretion of intravenously and orally administered [14C] telmisartan in healthy volunteers. J Clin Pharmacol 2000;40:1312–22.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao S, Kuge Y, et al. Elevated 18F-FDG levels in blood and organs after angiotensin II receptor blocker administration: experiment in mice administered telmisartan. J Nucl Med 2013;54:1384–8.
   PubMed Web of Science ®Google Scholar
• Kim HK, Youm JB, Lee SR, et al. The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action. Pflugers Arch 2012;464:631–43.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Takashima T, Yamane T, et al. Whole-body distribution and radiation dosimetry of [11 C] telmisartan as a biomarker for hepatic organic anion transporting polypeptide. Nuclear Med Biol 2012;39:847–53.
   PubMed Web of Science ®Google Scholar
• He S, Liang XF, Qu CM, et al. Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodonidella). Comp Biochem Physiol C Toxicol Pharmacol 2012;155:381–8.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Neuss M, Warnecke C, et al. Angiotensin receptors-organ and subtype specific regulation in cardiovascular diseases by modulation of the renin-angiotensin system. Studies of the rat model and in human myocardium. Z Kardiol 1995;84:61–9.
   PubMedGoogle Scholar
• Sahu K, Sahu S, Shaharyar M, et al. Comparative study of forced degradation behavior of telmisartan by UPLC and HPLC and development of validated stability indicating assay method according to ICH guidelines. J Chromat Separation Techniq 2012;3:1–6.
   Google Scholar
• Yuan H, Bao X, Du YZ, et al. Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery. Int J Nanomedicine 2012;7:5119–28.
   PubMed Web of Science ®Google Scholar
• Reddy LH, Sharma RK, Chuttani K, et al. Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies. AAPS J 2004;6:55–64.
   Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 2012;14:1–16.
   PubMed Web of Science ®Google Scholar
• Gratton SE, Ropp PA, Pohlhaus PD, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci USA 2008;105:11613–18.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006;6:662–8.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Liu Y, Wang LM, et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010;31:7606–19.
   PubMed Web of Science ®Google Scholar
• Liebert MA. Final report on the safety assessment of oleic acid, laurie acid, palmitic acid, myristic acid, and stearic acid. J Am College Toxicol 1987;6:321–401.
   Google Scholar
• Das S, Chaudhary A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011;12:62–76.
   PubMed Web of Science ®Google Scholar
• Cobos EJ, Entrena JM, Nieto FR, et al. Pharmacology and therapeutic potential of sigma1 receptor ligands. Curr Neuropharmacol 2008;6:344–66.
   PubMed Web of Science ®Google Scholar
• John CS, Vilner BJ, Geyer BC, et al. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors. Cancer Res 1999;59:4578–83.
   PubMed Web of Science ®Google Scholar
• Maurice T, Su TP. The pharmacology of sigma-1 receptors. Pharmacol Ther 2009;124:195–206.
   PubMed Web of Science ®Google Scholar
• Zeng C, Rothfuss J, Zhang J, et al. Sigma-2 ligands induce tumour cell death by multiple signalling pathways. Br J Cancer 2012;106:693–701.
   PubMed Web of Science ®Google Scholar
• Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor-cell lines. Cancer Res 1995;55:408–13.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Tyagi P, Li S, et al. Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells. Int J Cancer 2004;112:693–700.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Prasad TK, Rao NM, et al. Haloperidol-associated stealth liposomes: a potent carrier for delivering genes to human breast cancer cells. J Biol Chem 2005;22:5619–27.
   Google Scholar
• Zhang Y, Huang Y, Zhang P, et al. Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells. Int J Nanomedicine 2012;7:4473–85.
   PubMed Web of Science ®Google Scholar
• Wheeler KT, Wang LM, Wallen CA, et al. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 2000;82:1223–32.
   PubMed Web of Science ®Google Scholar
• Colabufo NA, Berardi F, Contino M, et al. Correlation between sigma-2 receptor protein expression and histopathologic grade in human bladder cancer. Cancer Lett 2006;237:83–8.
   PubMed Web of Science ®Google Scholar
• Spitzer D, Simon PO, Kashiwagi H, et al. Use of multifunctional sigma-2 receptor ligand conjugates to trigger cancer-selective cell death signaling. Cancer Res 2012;72:201–19.
   PubMed Web of Science ®Google Scholar
• Guo LW, Hajipour AR, Karaoglu K, et al. Development of benzophenone-alkyne bifunctional sigma receptor ligands. Chembiochem 2012;13:2277–89.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Gu F, Zhang L. Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther 2008;8:1063–70.
   PubMed Web of Science ®Google Scholar
• Mesangeau C, Narayanan S, Green AM, et al. Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity. J Med Chem 2008;51:1482–6.
   PubMed Web of Science ®Google Scholar
• Mach RH, Zeng C, Hawkins WG. The σ2 receptor: a novel protein for the imaging and treatment of cancer. J Med Chem 2013;56:7137–60.
   PubMed Web of Science ®Google Scholar
• Gibson MS, Bradshaw RW. The Gabriel synthesis of primary amines. Angew Chem Int Ed Engl 1968;7:919–30.
   Web of Science ®Google Scholar
• Kim SL, Jeong HJ, Kim EM, et al. Folate receptor targeted imaging using poly (ethylene glycol)-folate: in vitro and in vivo studies. J Korean Med Sci 2007;22:405–11.
   PubMed Web of Science ®Google Scholar
• British Pharmacopoeia, Volume II, 2010; 2042–2044.
   Google Scholar
• Hu FQ, Jiang SP, Du YZ, et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surfaces B Biointerfaces 2005;10:167–73.
   Web of Science ®Google Scholar
• Vogel R, Meredith P, Harvey MD, et al. Absorption and fluorescence spectroscopy of rhodamine 6G in titanium dioxide nanocomposites. Spectrochim Acta A Mol Biomol Spectrosc 2004;60:245–9.
   PubMed Web of Science ®Google Scholar
• Gupta PK, Hung CT, Perrier DG. Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis. J Pharm Sci 1987;76:141–5.
   PubMed Web of Science ®Google Scholar
• Anand O, Yu LX, Conner DP, et al. Dissolution testing for generic drugs: an FDA perspective. AAPS J 2011;13:328–35.
   PubMed Web of Science ®Google Scholar
• Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Kumano M, Miyake H, Kurahashi T, et al. Enhanced progression of human prostate cancer PC-3 cells induced by the microenvironment of the seminal vesicle. Br J Cancer 2008;98:356–62.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces 2010;79:113–25.
   PubMed Web of Science ®Google Scholar
• Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76–85.
   PubMed Web of Science ®Google Scholar
• Kim T, Park H. Computational prediction of octanol-water partition coefficient based on the extended solvent-contact model. J Mol Graph Model 2015;60:108–17.
   PubMed Web of Science ®Google Scholar
• Jabir NR, Tabrez S, Ashraf GM, et al. Nanotechnology-based approaches in anticancer research. Int J Nanomedicine 2012;7:4391–408.
   PubMed Web of Science ®Google Scholar
• Jenning V, Thunemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000;199:167–77.
   PubMed Web of Science ®Google Scholar
• Seetapan N, Bejrapha P, Srinuanchai W, et al. Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs). Micron 2010;41:51–8.
   PubMed Web of Science ®Google Scholar
• Wiens T, Redelmeier T, Av-Gay Y. Development of a liposome formulation of ethambutol. Antimicrob Agents Chemother 2004;48:1887–8.
   PubMed Web of Science ®Google Scholar
• Zeng C, Vangveravong S, Jones LA, et al. Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes. Mol Imaging 2011;10:420–33.
   PubMed Web of Science ®Google Scholar
• Zeng C, Vangveravong S, McDunn JE, et al. Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer. Br J Cancer 2013;109:2368–77.
   PubMed Web of Science ®Google Scholar